dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Trilla‑Fuertes, Lucía |
dc.contributor.author | Gámez‑Pozo, Angelo |
dc.contributor.author | Maurel, Joan |
dc.contributor.author | Garcia‑Carbonero, Rocio |
dc.contributor.author | G‑Pastrián, Laura |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.date.accessioned | 2021-11-24T09:08:33Z |
dc.date.available | 2021-11-24T09:08:33Z |
dc.date.issued | 2021-04-01 |
dc.identifier.citation | Trilla-Fuertes L, Gámez-Pozo A, Maurel J, Garcia-Carbonero R, Capdevila J, G-Pastrián L, et al. Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab. Sci Rep. 2021 Apr 1;11:7402. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/6591 |
dc.description | Càncer; Genètica mèdica; Marcadors predictius |
dc.description.sponsorship | LT-F is supported by the Spanish Economy and Competitiveness Ministry (DI-15-07614). |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Càncer - Anus - Tractament |
dc.subject | Càncer - Anus - Aspectes genètics |
dc.subject.mesh | Anus Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Genetic Variation |
dc.title | Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-021-86966-w |
dc.subject.decs | neoplasias del ano |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | variación genética |
dc.relation.publishversion | https://doi.org/10.1038/s41598-021-86966-w |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Trilla-Fuertes L] Biomedica Molecular Medicine SL, Madrid, Spain. [Gámez-Pozo A] Biomedica Molecular Medicine SL, Madrid, Spain. Molecular Oncology and Pathology Lab, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain. [Maurel J] Medical Oncology Department, Hospital Clinic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumors Group, IDIBAPS, University of Barcelona, Barcelona, Spain. [Garcia-Carbonero R] Medical Oncology Department, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), UCM, CNIO, CIBERONC, Hospital Universitario 12 de Octubre, Madrid, Spain. [Capdevila J] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [G-Pastrián L] Pathology Department, Hospital Universitario La Paz, Madrid, Spain. Molecular Pathology and Therapeutic Targets Group, Hospital Universitario La Paz-IdiPAZ, Madrid, Spain |
dc.identifier.pmid | 33795829 |
dc.identifier.wos | 000636797900032 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |